Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - betahistini dihydrochloridum - comprimés - betahistini dihydrochloridum 16 mg, cellulosum microcristallinum, mannitolum, acidum citricum monohydricum, silica colloidalis anhydrica, talcum, pro compresso. - vertiges - synthetika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - betahistini dihydrochloridum - comprimés - betahistini dihydrochloridum 24 mg, cellulosum microcristallinum, mannitolum, acidum citricum monohydricum, silica colloidalis anhydrica, talcum, pro compresso. - vertiges - synthetika

Switzerland - French - Swissmedic (Swiss Agency for Therapeutic Products)

mylan pharma gmbh - betahistini dihydrochloridum - solution - betahistini dihydrochloridum 8 mg, saccharinum natricum corresp. natrium 140 µg, ethanolum 96 per centum 50 µl, aqua purificata, aromatica (schokolade) cum ethanolum et phenylalaninum, propylis parahydroxybenzoas 200 µg, e 218 800 µg ad solutionem pro 1 ml corresp. ethanolum 5 % v/v. - vertiges - synthetika

Ireland - English - HPRA (Health Products Regulatory Authority)

abbott healthcare products ltd - betahistine hydrochloride - tablets - 8 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

abbott healthcare products ltd - betahistine hydrochloride - tablets - 16 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

viatris healthcare limited - betahistine hydrochloride - tablet - antivertigo preparations; betahistine

Ireland - English - HPRA (Health Products Regulatory Authority)

viatris healthcare limited - betahistine hydrochloride - tablet - antivertigo preparations; betahistine

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - betahistine dihydrochloride - oral tablet - 8mg

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

abbott laboratories (m) sdn. bhd. - betahistine dihydrochloride -

European Union - Polish - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - telmisartan - nadciśnienie - antagoniści angiotensyny ii, prosty - hypertensiontreatment nadciśnienia tętniczego u dorosłych. choroby układu sercowo-naczyniowego preventionreduction sercowonaczyniową chorobliwość u pacjentów z:manifest aterotrombotičeskih choroby sercowo-naczyniowe (w historii choroby niedokrwiennej serca, udaru mózgu lub choroby naczyń obwodowych) lub cukrzycy, cukrzycę typu 2, z задокументированным uszkodzenia narządów docelowych.